Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Karimah Es Sabar currently holds 53,735 shares of CAPRICOR THERAPEUTICS, INC. (CAPR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Karimah Es Sabar has been a net seller of CAPR stock. They have purchased $0 and sold $3.5M worth of shares.
Karimah Es Sabar's most recent insider trade was on Apr 1, 2026, when they sold 53,735 shares at $0.00 per share.
Karimah Es Sabar serves as Executive at CAPRICOR THERAPEUTICS, INC. (CAPR). They have executed 10 insider transactions totaling $3.5M over their tenure at the company.
Karimah Es Sabar holds the position of Executive at CAPRICOR THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Karimah Es Sabar has shown a selling trading pattern, with $0 in total purchases and $3.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Karimah Es Sabar was on Mar 31, 2026, when they sold $1.8M worth of CAPR shares. This transaction involved 61,265 shares at $30.17 per share.
Karimah Es Sabar currently owns 53,735 shares of CAPRICOR THERAPEUTICS, INC. (CAPR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Karimah Es Sabar's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Karimah Es Sabar has 10 Form 4 filings on record as an insider at CAPRICOR THERAPEUTICS, INC..
Set alerts for Karimah Es Sabar and 40,000+ other insiders.